Loading the stock brief
Stock brief · the live tape
BCYCBICYCLE THERAPEUTICS plc
Health Care · Pharmaceuticals, Biotechnology & Life Sciences · Nasdaq
$3.89
▼ $0.11 (-2.9%) · 30dclose Friday, October 9, 2026
No member of Congress has disclosed a trade in this ticker.
203 insider filings · 4 tracked funds
The Hillno disclosed congressional trade
The Boardroom
▲ 10▼ 109
10 buys · 109 sells · 203 filingsFeeding Time
▲ 3▼ 0
3 adding · 0 trimming · 4 holdingCAT Scan
No filing on BCYC counts toward a CAT Scan in the last year, so there is no number.
The tape
Price with a twin dot per disclosed trade: filled at the trade, hollow at the filing. The dashed gap is what the market did in between, not anyone’s return.
trade (insider)
The boardroom
Scheduled 10b5-1 sales are usually noise, set on autopilot months ago. The unscheduled ones are the ones to read.
Skynner MichaelCHIEF SCIENTIFIC OFFICERUnscheduled
Lee KevinCHIEF EXECUTIVE OFFICER, DirectorUnscheduled
Perry Jennifer ScottChief Operating OfficerUnscheduled
Hannay Michael Charles FergusonCHIEF PROD & SUPPLY CHAIN OFFUnscheduled
Thompson Travis AlvinChief Financial OfficerUnscheduled
Perry Jennifer ScottChief Operating OfficerScheduled · 10b5-1
Perry Jennifer ScottChief Operating OfficerUnscheduled
Lee KevinCHIEF EXECUTIVE OFFICER, DirectorUnscheduled
Skynner MichaelCHIEF SCIENTIFIC OFFICERUnscheduled
Hannay Michael Charles FergusonCHIEF PROD & SUPPLY CHAIN OFFUnscheduled
Thompson Travis AlvinChief Financial OfficerUnscheduled
Swanton Robert CharlesDirectorUnscheduled
Hannay Michael Charles FergusonCHIEF PROD & SUPPLY CHAIN OFFUnscheduled
Perry Jennifer ScottChief Operating OfficerUnscheduled
Skynner MichaelCHIEF SCIENTIFIC OFFICERUnscheduled
Thompson Travis AlvinChief Financial OfficerUnscheduled
Skynner MichaelCHIEF SCIENTIFIC OFFICERUnscheduled
Perry Jennifer ScottChief Operating OfficerUnscheduled
Perry Jennifer ScottChief Operating OfficerScheduled · 10b5-1
Thompson Travis AlvinChief Financial OfficerUnscheduled
Lee KevinCHIEF EXECUTIVE OFFICER, DirectorUnscheduled
Hannay Michael Charles FergusonCHIEF PROD & SUPPLY CHAIN OFFUnscheduled
Skynner MichaelCHIEF SCIENTIFIC OFFICERUnscheduled
Hannay Michael Charles FergusonCHIEF PROD & SUPPLY CHAIN OFFUnscheduled
Thompson Travis AlvinChief Financial OfficerUnscheduled
Lee KevinCHIEF EXECUTIVE OFFICER, DirectorUnscheduled
Perry Jennifer ScottChief Operating OfficerUnscheduled
Skynner MichaelCHIEF SCIENTIFIC OFFICERUnscheduled
Perry Jennifer ScottChief Operating OfficerUnscheduled
Thompson Travis AlvinChief Financial OfficerUnscheduled
Perry Jennifer ScottChief Operating OfficerScheduled · 10b5-1
Lee KevinCHIEF EXECUTIVE OFFICER, DirectorUnscheduled
Hannay Michael Charles FergusonCHIEF PROD & SUPPLY CHAIN OFFUnscheduled
Skynner MichaelCHIEF SCIENTIFIC OFFICERUnscheduled
Perry Jennifer ScottChief Operating OfficerUnscheduled
Thompson Travis AlvinChief Financial OfficerUnscheduled
Hannay Michael Charles FergusonCHIEF PROD & SUPPLY CHAIN OFFUnscheduled
Lee KevinCHIEF EXECUTIVE OFFICER, DirectorUnscheduled
Thompson Travis AlvinChief Financial OfficerUnscheduled
Skynner MichaelCHIEF TECHNOLOGY OFFICERUnscheduled
The fund book
Tracked 13F holders and how their position moved, quarter over quarter.
Baker Bros. Advisors LP$46.2M10.9M sharesheldRenaissance Technologies LLC$6.5M1.5M sharesaddedCitadel Advisors LLC$2.3M554K sharesaddedPoint72 Asset Management$636K150K sharesadded
Positions as filed for the quarter ending 30 Jun 2026, the latest on file. A 13F is a quarter-end photograph filed up to 45 days later, so this is where these funds stood then, not what they hold now. Common stock only: options and short positions are not in a 13F, and a fund that had already sold out does not appear.
⚠️ Public information, sourced from STOCK Act, Form 4 and 13F filings. Ranges use midpoints. Price paths between a trade and its filing are market moves, not anyone’s return. Not financial advice.